Venous thromboembolism incidence appeared high among patients with solid tumors who had implanted ports, according to study results. Risk factors for catheter-related VTE differed from the factors ...

Retrospective studies suggest that it may be safe to extend the maintenance flushing interval of implanted ports from once every month, as recommended by the manufacturer, to once every 3 months, but ...

Please provide your email address to receive an email when new articles are posted on . CHICAGO — Slow release of concentrated ranibizumab via a surgically implanted port delivery system demonstrated ...

Heterozygous Germline ATM Mutations Do Not Contribute to Radiation-Associated Malignancies After Hodgkin's Disease PURPOSE: To examine the safety, efficacy, costs, and impact on quality of life of ...

The US Food and Drug Administration for the first time approved an implant to treat neovascular age-related macular degeneration (nAMD). By releasing a constant dose of ranibizumab, the implanted port ...

ORLANDO, Fla.--(BUSINESS WIRE)--3M Critical and Chronic Care Solutions today announces the launch of its new 3M™ Tegaderm™ CHG Chlorhexidine Gluconate I.V. Port Dressing, designed for patients with ...